<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Catheter-related septic thrombophlebitis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Catheter-related septic thrombophlebitis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Catheter-related septic thrombophlebitis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Denis Spelman, MBBS, FRACP, FRCPA, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 18, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Catheter-related septic thrombophlebitis is a complication of catheter-related bloodstream infection (CRBSI). This usually involves inflammation and suppuration within the wall of the vein, infected thrombus within the lumen, surrounding soft tissue inflammation, and persistent bacteremia [<a href="#rid1">1</a>].</p><p>The epidemiology, microbiology, clinical manifestations, diagnosis, and treatment of catheter-related septic thrombophlebitis will be reviewed here. </p><p>Issues related to the epidemiology, pathogenesis, microbiology, clinical manifestations, diagnosis, treatment and prevention of CRBSI are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3806.html" rel="external">"Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology"</a> and  <a class="medical medical_review" href="/z/d/html/3813.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/3814.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Treatment"</a> and  <a class="medical medical_review" href="/z/d/html/15671.html" rel="external">"Routine care and maintenance of intravenous devices"</a>.)</p><p class="headingAnchor" id="H2401474813"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Catheter-related septic thrombophlebitis is a relatively uncommon complication of catheter-related bloodstream infection (CRBSI); in one series including 102 episodes of CRBSI, suppurative thrombophlebitis was observed in 7 percent of cases [<a href="#rid2">2</a>].</p><p>Risk factors for catheter-related septic thrombophlebitis include burns [<a href="#rid3">3</a>], cut-downs in burn patients for vein access [<a href="#rid4">4</a>], glucocorticoid use [<a href="#rid5">5</a>], and injection drug use [<a href="#rid6">6</a>]. Burn patients may be at particular risk due to a variety of factors (eg, altered skin flora, impairment of local defense due to loss of skin integrity) [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/14985.html" rel="external">"Burn wound infection and sepsis"</a>.)</p><p class="headingAnchor" id="H1220944128"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>The microbiology of catheter-related septic thrombophlebitis reflects the microbiology of catheter-related bloodstream infection. The most common cause is <em>Staphylococcus aureus</em> [<a href="#rid6">6,7</a>]; streptococci and Enterobacteriaceae are also well-described pathogens [<a href="#rid6">6,7</a>]. Burn patients may have polymicrobial infection [<a href="#rid8">8</a>]. (See  <a class="medical medical_review" href="/z/d/html/3806.html" rel="external">"Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology", section on 'Microbiology'</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL MANIFESTATIONS AND DIAGNOSIS</span><span class="headingEndMark"> — </span>Catheter-related septic thrombophlebitis should be suspected in patients with catheter-related bloodstream infection and persistent bacteremia after 72 hours of appropriate antibiotic therapy. Additional clinical manifestations may include fever, erythema, tenderness, a palpable cord, and purulent drainage at the site of the involved vessel [<a href="#rid6">6-8</a>]. Complications of septic thrombophlebitis include intravascular abscess, septic pulmonary emboli, and secondary pneumonia; these may also be presenting manifestations [<a href="#rid9">9-12</a>].</p><p>The diagnosis of catheter-related septic thrombophlebitis may be established based on radiographic evidence of thrombosis together with microbiology data. The presence of venous thrombosis may be established via duplex ultrasonography, contrast venography, or computed tomography scan with contrast [<a href="#rid13">13</a>]; the microbiologic diagnosis can be made based on culture of blood or purulent material expressed or surgically drained from the site. (See  <a class="medical medical_review" href="/z/d/html/3813.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H1519113292"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Catheter-related septic thrombophlebitis is a complication of catheter-related bloodstream infection (CRBSI); the differential diagnosis of CRBSI is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3813.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis", section on 'Differential diagnosis'</a>.) </p><p class="headingAnchor" id="H7"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>Principles of management include removing the focus of infection (eg, catheter removal), prompt administration of intravenous antibiotics, and consideration regarding the need for anticoagulation or surgical intervention. </p><p class="headingAnchor" id="H1659657374"><span class="h2">Catheter removal</span><span class="headingEndMark"> — </span>Catheter removal is warranted in the setting of septic thrombophlebitis, given high likelihood of progressive infection with antibiotic therapy alone.</p><p>In a retrospective study including 128 patients with <em>S. aureus </em>catheter-related septic thrombosis, central venous catheter removal or exchange within 48 hours of bacteremia onset was the only intervention with an association trend for fever and microbiologic resolution within 72 hours; these interventions were performed in 70 percent of patients with treatment success and 51 percent of patients with treatment failure [<a href="#rid13">13</a>]. </p><p>Issues related to catheter removal for patients with catheter-related bloodstream infection (CRBSI) are discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/3814.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Treatment", section on 'Selecting a catheter management strategy'</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">Antibiotic therapy</span><span class="headingEndMark"> — </span>The approach to selection of empiric and directed antibiotic therapy for catheter-related septic thrombophlebitis is the same as for treatment of CRBSI (<a class="graphic graphic_table graphicRef79387" href="/z/d/graphic/79387.html" rel="external">table 1</a>). Antibiotics should be tailored to culture and susceptibility data when available. (See  <a class="medical medical_review" href="/z/d/html/3814.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Treatment"</a>.)</p><p>After 48 to 72 hours of antibiotic therapy, we repeat duplex ultrasonography to evaluate for thrombus extension. Considerations regarding anticoagulation are discussed below. (See <a class="local">'Role of anticoagulation'</a> below.)</p><p>The optimal duration of antibiotic therapy for septic thrombophlebitis is uncertain. Given infection involving the vessel wall, we favor continuation of parenteral antimicrobial therapy for four weeks (rather than shorter durations as used for treatment of CRBSI in the absence of thrombus). </p><p>This approach is supported by a retrospective study including 128 patients with cancer and catheter-related septic thrombophlebitis due to <em>S. aureus</em>; higher all-cause mortality was observed among patients who received less than 28 days of therapy (31 versus 5 percent) [<a href="#rid13">13</a>]. </p><p class="headingAnchor" id="H10"><span class="h2">Role of anticoagulation</span><span class="headingEndMark"> — </span>The benefit of anticoagulation for management of catheter-related septic thrombophlebitis is uncertain; data are limited to retrospective studies and case reports [<a href="#rid13">13</a>]. </p><p>In general, we suggest not treating most patients with anticoagulation. In most cases, the major factors associated with induction of vascular inflammation and clotting are addressed by catheter removal and antibiotic administration.</p><p>We pursue anticoagulation in the setting of persistent manifestations of infection (such as fever, hemodynamic instability, bacteremia) after 48 to 72 hours of appropriate antimicrobial therapy or duplex ultrasonography evidence of thrombus extension despite appropriate antibiotic therapy.</p><p>Thrombolysis in individual case reports has been described [<a href="#rid14">14</a>], but this modality of therapy is rarely considered and is not recommended by the author.</p><p class="headingAnchor" id="H468402880"><span class="h2">Role of surgery</span><span class="headingEndMark"> — </span>In general, surgical intervention should be reserved for patients with persistent manifestations of infection despite appropriate antimicrobial therapy and anticoagulation [<a href="#rid6">6,15,16</a>]. </p><p>Potential surgical interventions include incision and drainage or excision of the affected vein and its tributaries [<a href="#rid4">4,7,17</a>]. Incision and drainage alone may be inadequate since it does not remove the septic focus and recurrent bacteremia can occur [<a href="#rid7">7,18</a>]. In one series including 24 cases of infected cut-downs among burn patients, 7 of 10 treated surgically survived; for 13 of the remaining 14, the diagnosis was only made at autopsy [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H29"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathophysiology and risk factors</strong> – Catheter-related septic thrombophlebitis is a relatively uncommon complication of catheter-related bloodstream infection (CRBSI). It typically involves inflammation and suppuration within the wall of the vein, infected thrombus within the lumen, surrounding soft tissue inflammation, and persistent bacteremia. Patients at increased risk include those with burns, glucocorticoid use, and injection drug use. (See <a class="local">'Introduction'</a> above and <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – The microbiology of catheter-related septic thrombophlebitis reflects the microbiology of CRBSI. The most common cause is <em>Staphylococcus aureus</em>; streptococci and Enterobacteriaceae are also well-described pathogens. Burn patients may have polymicrobial infection. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Catheter-related septic thrombophlebitis should be suspected in patients with CRBSI and persistent bacteremia after 72 hours of appropriate antibiotic therapy. Additional clinical manifestations may include fever, erythema, tenderness, a palpable cord, and purulent drainage at the site of the involved vessel. Complications of septic thrombophlebitis include intravascular abscess, septic pulmonary emboli, and secondary pneumonia; these may also be presenting manifestations. (See <a class="local">'Clinical manifestations and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of catheter-related septic thrombophlebitis may be established based on radiographic evidence of thrombosis together with microbiology data. The presence of venous thrombosis may be established via duplex ultrasonography, contrast venography, or computed tomography scan with contrast; the microbiologic diagnosis can be made based on culture of blood or purulent material expressed or surgically drained from the site. (See <a class="local">'Clinical manifestations and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Principles of management for catheter-related septic thrombophlebitis include removing the focus of infection (eg, catheter removal), prompt administration of intravenous antibiotics, and consideration regarding the need for anticoagulation or surgical intervention (see <a class="local">'Management'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role of catheter removal</strong> – We suggest catheter removal given high likelihood of progressive infection with antibiotic therapy alone (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Catheter removal'</a> above and  <a class="medical medical_review" href="/z/d/html/3814.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Treatment", section on 'Selecting a catheter management strategy'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antibiotic selection</strong> – The approach to selection of antibiotic therapy for catheter-related septic thrombophlebitis is the same as for treatment of CRBSI (<a class="graphic graphic_table graphicRef79387" href="/z/d/graphic/79387.html" rel="external">table 1</a>). Antibiotics should be tailored to culture and susceptibility data when available. After 48 to 72 hours of antibiotic therapy, we repeat duplex ultrasonography to evaluate for thrombus extension. (See <a class="local">'Antibiotic therapy'</a> above and  <a class="medical medical_review" href="/z/d/html/3814.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Treatment"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Duration of therapy</strong> – We suggest continuation of parenteral antimicrobial therapy for four weeks (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). The optimal duration of antibiotic therapy is uncertain; while shorter durations are given for uncomplicated CRBSI infection, we favor a longer course for infections involving the vessel wall. (See <a class="local">'Antibiotic therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role of anticoagulation</strong> – In general, we suggest not treating most patients with anticoagulation (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). In most cases, the major factors associated with induction of vascular inflammation and clotting are addressed by catheter removal and antibiotic administration. We pursue anticoagulation in the setting of persistent manifestations of infection (such as fever, hemodynamic instability, bacteremia) after 48 to 72 hours of appropriate antimicrobial therapy or duplex ultrasonography evidence of thrombus extension despite appropriate antibiotic therapy. (See <a class="local">'Role of anticoagulation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role of surgery</strong> – In general, surgical intervention should be reserved for patients with persistent manifestations of infection despite appropriate antimicrobial therapy and anticoagulation. Potential surgical interventions include incision and drainage or excision of the affected vein and its tributaries. (See <a class="local">'Role of surgery'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1.</a></li><li><a class="nounderline abstract_t">Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993; 16:778.</a></li><li><a class="nounderline abstract_t">Pruitt BA Jr, McManus WF, Kim SH, Treat RC. Diagnosis and treatment of cannula-related intravenous sepsis in burn patients. Ann Surg 1980; 191:546.</a></li><li><a class="nounderline abstract_t">Stein JM, Pruitt BA Jr. Suppurative thrombophlebitis. A lethal iatrogenic disease. N Engl J Med 1970; 282:1452.</a></li><li><a class="nounderline abstract_t">Strinden WD, Helgerson RB, Maki DG. Candida septic thrombosis of the great central veins associated with central catheters. Clinical features and management. Ann Surg 1985; 202:653.</a></li><li><a class="nounderline abstract_t">Baker CC, Petersen SR, Sheldon GF. Septic phlebitis: a neglected disease. Am J Surg 1979; 138:97.</a></li><li><a class="nounderline abstract_t">Khan EA, Correa AG, Baker CJ. Suppurative thrombophlebitis in children: a ten-year experience. Pediatr Infect Dis J 1997; 16:63.</a></li><li><a class="nounderline abstract_t">O'Neill JA Jr, Pruitt BA Jr, Foley FD, Moncrief JA. Suppurative thrombophlebitis--a lethal complication of intravenous therapy. J Trauma 1968; 8:256.</a></li><li><a class="nounderline abstract_t">Sinave CP, Hardy GJ, Fardy PW. The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection. Medicine (Baltimore) 1989; 68:85.</a></li><li><a class="nounderline abstract_t">Volkow P, Cornejo-Juárez P, Arizpe-Bravo AB, et al. Catheter-related septic thrombophlebitis of the great central veins successfully treated with low-dose streptokinase thrombolysis and antimicrobials. Thromb J 2005; 3:11.</a></li><li><a class="nounderline abstract_t">Cox ER, Amoroso A, Gilliam BL. Pannus attack: septic thrombophlebitis. Am J Med 2012; 125:1175.</a></li><li><a class="nounderline abstract_t">Ho VT, Rothenberg KA, McFarland G, et al. Septic Pulmonary Emboli From Peripheral Suppurative Thrombophlebitis: A Case Report and Literature Review. Vasc Endovascular Surg 2018; 52:633.</a></li><li><a class="nounderline abstract_t">Wilson Dib R, Chaftari AM, Hachem RY, et al. Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy. Open Forum Infect Dis 2018; 5:ofy249.</a></li><li><a class="nounderline abstract_t">Farny B, Vacheron CH, Friggeri A, Allaouchiche B. Septic Thrombophlebitis with Persistent Bacteremia Treated by Thrombolysis. Turk J Anaesthesiol Reanim 2022; 50:145.</a></li><li><a class="nounderline abstract_t">Andes DR, Urban AW, Acher CW, Maki DG. Septic thrombosis of the basilic, axillary, and subclavian veins caused by a peripherally inserted central venous catheter. Am J Med 1998; 105:446.</a></li><li><a class="nounderline abstract_t">Kim M, Kwon H, Hong SK, et al. Surgical treatment of central venous catheter related septic deep venous thrombosis. Eur J Vasc Endovasc Surg 2015; 49:670.</a></li><li><a class="nounderline abstract_t">Villani C, Johnson DH, Cunha BA. Bilateral suppurative thrombophlebitis due to Staphylococcus aureus. Heart Lung 1995; 24:342.</a></li><li><a class="nounderline abstract_t">Kniemeyer HW, Grabitz K, Buhl R, et al. Surgical treatment of septic deep venous thrombosis. Surgery 1995; 118:49.</a></li></ol></div><div id="topicVersionRevision">Topic 2131 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19489710" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8329510" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Consequences of intravascular catheter sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7369818" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Diagnosis and treatment of cannula-related intravenous sepsis in burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5419294" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Suppurative thrombophlebitis. A lethal iatrogenic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4051612" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Candida septic thrombosis of the great central veins associated with central catheters. Clinical features and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/464215" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Septic phlebitis: a neglected disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9002104" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Suppurative thrombophlebitis in children: a ten-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4868813" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Suppurative thrombophlebitis--a lethal complication of intravenous therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2646510" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16111500" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Catheter-related septic thrombophlebitis of the great central veins successfully treated with low-dose streptokinase thrombolysis and antimicrobials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23062405" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Pannus attack: septic thrombophlebitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29909751" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Septic Pulmonary Emboli From Peripheral Suppurative Thrombophlebitis: A Case Report and Literature Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30377625" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35544255" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Septic Thrombophlebitis with Persistent Bacteremia Treated by Thrombolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9831430" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Septic thrombosis of the basilic, axillary, and subclavian veins caused by a peripherally inserted central venous catheter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25784507" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Surgical treatment of central venous catheter related septic deep venous thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7591803" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Bilateral suppurative thrombophlebitis due to Staphylococcus aureus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7604379" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Surgical treatment of septic deep venous thrombosis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
